Streamlining Percutaneous Coronary Intervention Prior Authorization for Oncology Patients

The Clinical Intersection: PCI in the Oncology Patient Journey

Percutaneous Coronary Intervention (PCI) may be required for oncology patients due to pre-existing coronary artery disease, new-onset cardiac events exacerbated by cancer or its treatment, or as a necessary intervention prior to major oncologic surgery. Cardiotoxic agents, such as anthracyclines or certain targeted therapies, can precipitate or worsen cardiac conditions, making timely PCI crucial for maintaining cardiac function and enabling continued cancer treatment.

Navigating Prior Authorization Challenges for Dual-Specialty Care

The prior authorization process for PCI in oncology patients must reconcile the medical necessity criteria for a cardiac procedure with the overarching oncology treatment plan and patient prognosis. This often involves coordinating documentation and clinical rationale from both cardiology and oncology teams, a process prone to delays if not managed efficiently. The urgency of cancer treatment initiation or continuation adds another layer of complexity, as PA delays for PCI can directly impact oncologic outcomes.

Key Documentation Considerations for PCI in Oncology

• **Comprehensive Patient History:** Detailing both cardiac and oncologic diagnoses, including tumor type, stage, and current cancer treatment regimen.
• **Cardiology Evaluation:** Standard documentation including EKG, cardiac biomarkers, imaging (e.g., echocardiogram, stress test, angiogram findings) supporting the medical necessity of PCI.
• **Oncology Rationale:** Statement from the treating oncologist outlining the impact of the cardiac condition on cancer treatment, the urgency of PCI, and how PCI enables or optimizes the oncology care plan, often referencing NCCN guidelines for cancer management.
• **Performance Status:** ECOG or Karnofsky score, reflecting the patient's overall fitness for both the cardiac procedure and ongoing cancer therapy.
• **Multidisciplinary Care Plan:** Evidence of coordination between cardiology and oncology teams, demonstrating a unified approach to patient management.

Payer Review and Common Denial Themes

Payers meticulously review PCI requests, particularly when a patient has a complex medical history like active cancer. Denials often arise from insufficient documentation linking the PCI to the overall care goals, or from questions regarding the patient's prognosis and whether the intervention aligns with the payer's medical necessity criteria for the specific cardiac procedure. Denials may also stem from perceived lack of urgency or alternative treatment options, requiring robust clinical justification to overcome.

Klivira's Solution for Complex Multi-Specialty Prior Authorization

Klivira's prior authorization automation platform is engineered to manage the intricate demands of procedures like Percutaneous Coronary Intervention for oncology patients. Our system integrates with EMRs to pull relevant clinical data from both cardiology and oncology notes, applies payer-specific rules and NCCN-compendium-aware logic, and facilitates the submission of comprehensive, evidence-based PA requests. This approach minimizes manual effort, reduces submission errors, and accelerates approval times for these critical interventions.